-
CCRM is excited to launch a brand new initiative. We are answering your Qs on a variety of topics related to
#CARTs#CGTs#GMP working with#CDMOs...and if you don't know these acronyms, you should definitely check it out! https://www.ccrm.ca/cdmo_education_centre …#Biotechnology#STEMpic.twitter.com/aad829JLKi -


#countdown#Christmas#53Biologics Our#mission is to provide#services to different companies, from start-ups to large companies, as well as to other#CDMOs, to help their products to reach the market#pharma#biotecnology#biotech#microbiologypic.twitter.com/IvEvlubW46
-
What's the cost of selecting the right
#CRO? Make sure you are aware of all of the tests possible and contact us if you need help getting recommended CROs and#CDMOs! https://blog.rheosense.com/cros-cdmo -
We are so very proud to share the news about our
#FDA approval!! This achievement positions us at the level of the most distinguished#CDMOs in the world and represents a very important breakthrough in the history of 3P. https://www.3pbio.com/2019/09/18/3p-biopharmaceuticals-receives-fda-approval/ … pic.twitter.com/RfExhOFPxR
-
Discover insider information from a recent roundtable discussion about the use of
#CDMOs and what companies are looking for from them and much more. Download your copy here http://bit.ly/2uGKQZq pic.twitter.com/UR98IGwsCr
-
‘Lack of good CDMOs’ factor for Krystal’s $90m gene therapy plant https://buff.ly/2u9eTcv
#biotech#startups#CDMOs via@Xconomy -
Lack of good
#CDMOs a factor for@KrystalBiotech in investing $70-90m into internal PA gene therapy plant https://buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
-
"Outsourcing is a very effective way for pharma companies to tap into additional formulation expertise.” Our Global VP Innovator Products and Solutions, Nick Shackley, examines the growing partnership between
#CDMOs and#Pharma in@medicine_maker: https://bit.ly/2E6DcK1 pic.twitter.com/KSObEAxEMA
-
On 12 November we organise with
@biocat_en the workshop 'Technologies for improving bioavalilability of poorly water-soluble#drugs' by Dr A. Loxley, consultant of#ParticleSciences (@LZLifeSciHealth), one of the world's leading#CDMOs
https://bit.ly/31JnoFZ
Don't miss it!
pic.twitter.com/WPl44nAwmQ
-
.
@Cenmag interviewed Michel Lagarde, Executive VP of Thermo Fisher Scientific, about the challenges#CDMOs are facing as the pharma and#biotech markets rapidly grow.https://bit.ly/2Mq8Qqh -
Ready to use next-gen technology platforms and shift in portfolios from large volumes but simple, to lower volumes but complex or orphan molecules or even the lack of approved capacity for complex/sterile drugs are some reasons the
#CDMOs have started to feel real +ve traction.Prikaži ovu nit -
Pharma
#CDMOS: long time veteran observer and good friend Jim Miller reflects on 20+ years’ learnings at#PBOACON19@PBOAssocpic.twitter.com/AM6hVZ8XHL
-
The
#pharmaceuticalindustry continues to grow and is estimated at $1.5 trillion by 2021. An important driver is the trend to#outsource development and manufacturing to#CDMOs. We have asked executives working in this market to share their experiences. http://bit.ly/2Na7eTf pic.twitter.com/PgJ6CQFqg3
-
Supply chain digitization creates new revenue opportunities in the vaccine market via
@HPN_Online http://ow.ly/PFu130pBZyb#SupplyChain#HealthcareSupplyChain#Vaccines#PublicHealth#CDMOs -
In order to capitalize on the trend to outsource product development and manufacturing,
#CDMOs need to continuously optimize their#commercial strategy by establishing and enforcing a value-based pricing concept. Our experts commented for@CHEManager_EU. http://bit.ly/2QfKNhC pic.twitter.com/Fb993Psw9r
-
In this panel at
#PharmaIntegrates, we examine the future of#largemolecules vs#smallmolecules and the implications for#CDMOs. Panellists represent@AlcamiNow,@LillyPad,@XenoGesis,@pfizer and@AstraZeneca. Find out more: https://www.lifescienceintegrates.com/pharma-integrates-agenda-2019/ …#pharmapic.twitter.com/m2cfNCEuDE
-
"A good CDMO is not just about doing what they are told – the best are also consultants and collaborators.” Our Global VP Innovator Products and Solutions, Nick Shackley, shares his insights on partnerships between
#CDMOs and#Pharma in@medicine_maker: https://bit.ly/2E6DcK1 pic.twitter.com/fV9WDFKKLa
-
Useful info! Looking forward to watching the videos from
@TO_dpr. Thanks@clinicaltrialON for sharing the news about@CCRM_ca's new technical blogs that answer Qs about#CDMOs,#regulatoryaffairs,#CARTs working with#bioreactors and more. https://www.ccrm.ca/cdmo_education_centre …https://twitter.com/AndyDonovanCFRE/status/1148943413057871872 …Prikaži ovu nit -
This week in pharma... mega
#CDMOs impacting M&A,#FDA calls on help for#blockchain T&T tech,#genetherapy costs a headache for regulators and more…
https://www.ramarketingpr.com/this-week-in-pharma-17th-june/ … -
#BioIntegrates is tomorrow! We're sold out with lots of great speakers and insightful panel discussions. Registration is from 8am so see you then! https://www.lifescienceintegrates.com/bio-integrates-agenda-2019/ …#lifesciences#biotech#CDMOs#CROs#pharmapic.twitter.com/6JuAJYW21V
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.